DE3856052D1 - Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus - Google Patents

Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus

Info

Publication number
DE3856052D1
DE3856052D1 DE3856052T DE3856052T DE3856052D1 DE 3856052 D1 DE3856052 D1 DE 3856052D1 DE 3856052 T DE3856052 T DE 3856052T DE 3856052 T DE3856052 T DE 3856052T DE 3856052 D1 DE3856052 D1 DE 3856052D1
Authority
DE
Germany
Prior art keywords
deoxynojirimycin
medicament
manufacture
inhibiting
hiv virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3856052T
Other languages
English (en)
Other versions
DE3856052T2 (de
Inventor
Raymond Allen Dwek
George William John Fleet
Thomas William Rademacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/248,461 external-priority patent/US4849430A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DE3856052D1 publication Critical patent/DE3856052D1/de
Publication of DE3856052T2 publication Critical patent/DE3856052T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE3856052T 1987-12-21 1988-12-20 Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus Expired - Fee Related DE3856052T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13622487A 1987-12-21 1987-12-21
US16606588A 1988-03-09 1988-03-09
US07/248,461 US4849430A (en) 1988-03-09 1988-09-23 Method of inhibiting virus

Publications (2)

Publication Number Publication Date
DE3856052D1 true DE3856052D1 (de) 1997-11-27
DE3856052T2 DE3856052T2 (de) 1998-02-19

Family

ID=27384837

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3856052T Expired - Fee Related DE3856052T2 (de) 1987-12-21 1988-12-20 Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus

Country Status (15)

Country Link
EP (1) EP0324328B1 (de)
JP (1) JPH01203326A (de)
KR (1) KR910010020B1 (de)
AT (1) ATE159427T1 (de)
AU (1) AU605661B2 (de)
CA (1) CA1316459C (de)
DE (1) DE3856052T2 (de)
DK (1) DK175094B1 (de)
ES (1) ES2108680T3 (de)
GR (1) GR3025518T3 (de)
IE (1) IE81173B1 (de)
IL (1) IL88740A (de)
NZ (1) NZ227411A (de)
OA (1) OA09027A (de)
PT (1) PT89266B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DK1030839T3 (da) * 1997-11-10 2004-05-03 Searle & Co Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens
ATE331515T1 (de) 1998-02-12 2006-07-15 Searle Llc Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
AU3595500A (en) 1999-02-12 2000-08-29 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
EP2399587A1 (de) * 2006-08-02 2011-12-28 The University of Oxford Liposomenbehandlung von Virusinfektionen
CN115806913B (zh) * 2022-10-21 2023-09-08 福建省农业科学院植物保护研究所 野尻链霉菌（Streptomyces nojiriensis）菌株9-13及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
JPS5311800A (en) * 1976-07-20 1978-02-02 Asahi Chemical Ind Method of well preserving and transporting live fish and apparatus therefor
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
KR910010020B1 (ko) 1991-12-10
PT89266A (pt) 1989-12-29
IE883793L (en) 1989-06-21
IL88740A (en) 1993-01-31
IE81173B1 (en) 2000-05-31
JPH01203326A (ja) 1989-08-16
ES2108680T3 (es) 1998-01-01
OA09027A (fr) 1991-03-31
KR890009401A (ko) 1989-08-01
DK707988D0 (da) 1988-12-20
GR3025518T3 (en) 1998-02-27
EP0324328A2 (de) 1989-07-19
IL88740A0 (en) 1989-07-31
DK175094B1 (da) 2004-06-01
AU2706788A (en) 1989-06-22
EP0324328A3 (de) 1990-06-20
DE3856052T2 (de) 1998-02-19
NZ227411A (en) 1997-03-24
PT89266B (pt) 1993-11-30
CA1316459C (en) 1993-04-20
EP0324328B1 (de) 1997-10-22
JPH0521891B2 (de) 1993-03-25
ATE159427T1 (de) 1997-11-15
DK707988A (da) 1989-06-22
AU605661B2 (en) 1991-01-17

Similar Documents

Publication Publication Date Title
SE8704298D0 (sv) Compounds for use in therapy
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE120644T1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
FI925342A (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE3856052D1 (de) Anwendung des N-n-butyl-Derivates von Desoxynojirimycin zur Herstellung eines Arzneimittels zur Inhibierung von HIV-Virus
DK538888A (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
DE69430940D1 (de) Methode zur Behandlung von resistenten Neoplasmen
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
DE3850154T2 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE69019404T2 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
EP0342565A3 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee